Skip to main content

Obstetric, Antenatal, and Postpartum Care for Transgender and Nonbinary People

  • Chapter
  • First Online:
Reproduction in Transgender and Nonbinary Individuals

Abstract

Caring for transmasculine individuals includes caring for their reproductive needs and providing optimal preconception and pregnancy care. Pregnancy care of transmasculine individuals is similar to the care for cisgender women but includes some unique aspects. There is a paucity of data to guide healthcare providers on how to care for the pregnancies of transmasculine individuals. Guiding principles of care include ensuring that proper terminology is used when referring to anatomy and pregnancy, practicing trauma-informed care, and awareness of how gender and racial minority stress can impact the health and outcomes of this population. Preconception care of transmasculine individuals includes shared decision-making around when to stop gender-affirming hormones and pays particular attention to the health disparities that transmasculine people face that can affect their pregnancies and neonates. Antepartum care includes counseling around disclosure of pregnancy, psychosocial support around possibly increased gender dysphoria, and preferences around mode and location of delivery. Additional data is needed around pregnancy outcomes in transmasculine patients to determine risks of adverse outcomes. Postpartum care includes chestfeeding, restarting gender-affirming hormones, screening for postpartum depression, and ensuring contraceptive needs are met. We briefly touch on induction of lactation in transfeminine individuals. As with cisgender individuals, pregnant transmasculine individuals should be counseled on all their options regarding pregnancy, including providing access to abortion care.

To improve and optimize the care for transgender individuals, providers and clinic staff should be trained on how to provide sensitive and affirming care to transgender individuals. Intake forms and signage should be gender neutral and inclusive. By addressing barriers and stigma that transgender people face in society and in healthcare we can optimize the healthcare delivery and improve the health of our transgender patients.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 69.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 89.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 119.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Sharman Z, editor. The remedy: queer and trans voices on health and health care. 1st ed. Vancouver: Arsenal Pulp Press; 2016. 256 p

    Google Scholar 

  2. Schneider DM. American kinship: a cultural account. Chicago: University of Chicago Press; 1980. 149 p

    Book  Google Scholar 

  3. Weston K. Families we choose: lesbians, gays, kinship. New York: Columbia University Press; 1997 [cited 2020 Dec 30]. Available from http://ebookcentral.proquest.com/lib/umichigan/detail.action?docID=991398

  4. Jackson Levin N, Kattari SK, Piellusch EK, Watson E. “We just take care of each other”: navigating ‘chosen family’ in the context of health, illness, and the mutual provision of care amongst queer and transgender young adults. Int J Environ Res Public Health. 2020;17(19):7346.

    Article  Google Scholar 

  5. Moseson H, Fix L, Hastings J, Stoeffler A, Lunn MR, Flentje A, et al. Pregnancy intentions and outcomes among transgender, nonbinary, and gender-expansive people assigned female or intersex at birth in the United States: results from a national, quantitative survey. Int J Transgend Health. 2020;22(1–2):1–12.

    Google Scholar 

  6. USTS-Full-Report-FINAL.pdf [cited 2020 Dec 22]. Available from https://www.transequality.org/sites/default/files/docs/USTS-Full-Report-FINAL.PDF

  7. Ellis SA, Wojnar DM, Pettinato M. Conception, pregnancy, and birth experiences of male and gender variant gestational parents: it’s how we could have a family. J Midwifery Womens Health. 2015;60(1):62–9.

    Article  Google Scholar 

  8. Stroumsa D, Wu JP. Welcoming transgender and nonbinary patients: expanding the language of “women’s health”. Am J Obstet Gynecol. 2018;219(6):585.e1–5.

    Article  Google Scholar 

  9. Singer RB, Crane B, Lemay EP, Omary S. Improving the knowledge, attitudes, and behavioral intentions of perinatal care providers toward childbearing individuals identifying as LGBTQ: a quasi-experimental study. J Contin Educ Nurs. 2019;50(7):303–12.

    Article  Google Scholar 

  10. Tan KKH, Treharne GJ, Ellis SJ, Schmidt JM, Veale JF. Gender minority stress: a critical review. J Homosex. 2020;67(10):1471–89.

    Article  Google Scholar 

  11. Christian R, Mellies AA, Bui AG, Lee R, Kattari L, Gray C. Measuring the health of an invisible population: lessons from the Colorado transgender health survey. J Gen Intern Med. 2018;33(10):1654–60.

    Article  Google Scholar 

  12. Malmquist A, Jonsson L, Wikström J, Nieminen K. Minority stress adds an additional layer to fear of childbirth in lesbian and bisexual women, and transgender people. Midwifery. 2019;79:102551.

    Article  Google Scholar 

  13. Stroumsa D, Roberts EFS, Kinnear H, Harris LH. The power and limits of classification—a 32-year-old man with abdominal pain. N Engl J Med. 2019;380(20):1885–8.

    Article  Google Scholar 

  14. Rosenthal L, Lobel M. Explaining racial disparities in adverse birth outcomes: unique sources of stress for Black American women. Soc Sci Med. 2011;72(6):977–83.

    Article  Google Scholar 

  15. Grant JM, Motter LA, Tanis J. Injustice at every turn: a report of the national transgender discrimination survey. 2011 [cited 2020 Dec 11]; Available from https://dataspace.princeton.edu/handle/88435/dsp014j03d232p

  16. Craig SL, Austin A, Levenson J, Leung VWY, Eaton AD, D’Souza SA. Frequencies and patterns of adverse childhood events in LGBTQ+ youth. Child Abuse Negl. 2020;107:104623.

    Article  Google Scholar 

  17. Felitti VJ, Anda RF, Nordenberg D, Williamson DF, Spitz AM, Edwards V, et al. Relationship of childhood abuse and household dysfunction to many of the leading causes of death in adults: the Adverse Childhood Experiences (ACE) study. Am J Prev Med. 1998;14(4):245–58.

    Article  CAS  Google Scholar 

  18. SAMHSA’s concept of trauma and guidance for a trauma-informed approach:27. 2014.

    Google Scholar 

  19. Guttmacher Institute. Abortion incidence and service availability in the United States, 2017. 2019 [cited 2021 Jan 19]. Available from https://www.guttmacher.org/report/abortion-incidence-service-availability-us-2017

  20. Jones RK, Witwer E, Jerman J. Transgender abortion patients and the provision of transgender-specific care at non-hospital facilities that provide abortions. Contracept X. 2020;2:100019.

    Article  Google Scholar 

  21. Moseson H. Abortion experiences and preferences of transgender, nonbinary, and gender-expansive people in the United States. Am J Obstet Gynecol. 2020 [cited 2020 Oct 9]; Available from http://www.sciencedirect.com/science/article/pii/S0002937820311261

  22. Limburg A, Everett BG, Mollborn S, Kominiarek MA. Sexual orientation disparities in preconception health. J Women’s Health. 2020;29(6):755–62.

    Article  Google Scholar 

  23. Stroumsa D, Johnson TRB. Improving preconception health among sexual minority women. J Women’s Health. 2020;29(6):745–7.

    Article  Google Scholar 

  24. Prepregnancy Counseling [cited 2020 Dec 21]. Available from https://www.acog.org/en/Clinical/Clinical Guidance/Committee Opinion/Articles/2019/01/Prepregnancy Counseling

  25. ACOG. Carrier screening for genetic conditions. [cited 2021 Mar 5]. Available from https://www.acog.org/clinical/clinical-guidance/committee-opinion/articles/2017/03/carrier-screening-for-genetic-conditions

  26. Light AD, Obedin-Maliver J, Sevelius JM, Kerns JL. Transgender men who experienced pregnancy after female-to-male gender transitioning. Obstet Gynecol. 2014 Dec;124(6):1120–7.

    Article  CAS  Google Scholar 

  27. Moravek MB, Kinnear HM, George J, Batchelor J, Shikanov A, Padmanabhan V, et al. Impact of exogenous testosterone on reproduction in transgender men. Endocrinology. 2020;161(3):bqaa014.

    Article  Google Scholar 

  28. Caanen MR, Soleman RS, Kuijper EAM, Kreukels BPC, De Roo C, Tilleman K, et al. Antimüllerian hormone levels decrease in female-to-male transsexuals using testosterone as cross-sex therapy. Fertil Steril. 2015;103(5):1340–5.

    Article  CAS  Google Scholar 

  29. Carrasco A, Recabarren MP, Rojas-García PP, Gutiérrez M, Morales K, Sir-Petermann T, et al. Prenatal testosterone exposure disrupts insulin secretion and promotes insulin resistance. Sci Rep. 2020;10(1):404.

    Article  CAS  Google Scholar 

  30. Hakim C, Padmanabhan V, Vyas AK. Gestational hyperandrogenism in developmental programming. Endocrinology. 2016;158(2):199–212.

    Article  Google Scholar 

  31. World Anti-Doping Agency. TUE physician guidelines- male hypogonadism. 2019. Available from https://www.wada-ama.org/sites/default/files/resources/files/tuec_malehypogonadism_version6.2.pdf

  32. Arab K, Spence AR, Czuzoj-Shulman N, Abenhaim HA. Pregnancy outcomes in HIV-positive women: a retrospective cohort study. Arch Gynecol Obstet. 2017;295(3):599–606.

    Article  Google Scholar 

  33. Becasen JS, Denard CL, Mullins MM, Higa DH, Sipe TA. Estimating the prevalence of HIV and sexual behaviors among the US transgender population: a systematic review and meta-analysis, 2006–2017. Am J Public Health. 2019;109(1):e1–8.

    Article  Google Scholar 

  34. U.S. Statistics. U.S. Statistics, 2020. HIVgov 2020 [cited 2021 Jan 21]. Available from https://www.hiv.gov/hiv-basics/overview/data-and-trends/statistics

  35. Mandelbrot L, Tubiana R, Le Chenadec J, Dollfus C, Faye A, Pannier E, et al. No perinatal HIV-1 transmission from women with effective antiretroviral therapy starting before conception. Clin Infect Dis. 2015;61(11):1715–25.

    Google Scholar 

  36. ClinicalInfo. Overview. Recommendations for use of antiretroviral drugs during pregnancy. Antepartum care. Perinatal. [cited 2021 Feb 19]. Available from https://clinicalinfo.hiv.gov/en/guidelines/perinatal/overview-2?view=full

  37. Zash R, Holmes L, Diseko M, Jacobson DL, Brummel S, Mayondi G, et al. Neural-tube defects and antiretroviral treatment regimens in Botswana. N Engl J Med. 2019;381(9):827–40.

    Article  CAS  Google Scholar 

  38. Zamek-Gliszczynski MJ, Zhang X, Mudunuru J, Du Y, Chen J-L, Taskar KS, et al. Clinical extrapolation of the effects of dolutegravir and other HIV integrase inhibitors on folate transport pathways. Drug Metab Dispos. 2019;47(8):890–8.

    Article  CAS  Google Scholar 

  39. Cabrera RM, Souder JP, Steele JW, Yeo L, Tukeman G, Gorelick DA, et al. The antagonism of folate receptor by dolutegravir: developmental toxicity reduction by supplemental folic acid. AIDS. 2019;33(13):1967–76.

    Article  CAS  Google Scholar 

  40. US Preventive Services Task Force, Curry SJ, Krist AH, Owens DK, Barry MJ, Caughey AB, et al. Screening for cervical cancer: US Preventive Services Task Force recommendation statement. JAMA. 2018;320(7):674.

    Article  Google Scholar 

  41. Peitzmeier SM, Reisner SL, Harigopal P, Potter J. Female-to-male patients have high prevalence of unsatisfactory Paps compared to non-transgender females: implications for cervical cancer screening. J Gen Intern Med. 2014;29(5):778–84.

    Article  Google Scholar 

  42. Forray A. Substance use during pregnancy. F1000Research. 2016 [cited 2021 Feb 9];5. Available from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4870985/

  43. Parent MC, Arriaga AS, Gobble T, Wille L. Stress and substance use among sexual and gender minority individuals across the lifespan. Neurobiol Stress 2018 [cited 2021 Mar 5];10. Available from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6430403/

  44. Reisner SL, Pardo ST, Gamarel KE, Hughto JMW, Pardee DJ, Keo-Meier CL. Substance use to cope with stigma in healthcare among U.S. female-to-male trans masculine adults. LGBT Health. 2015;2(4):324–32.

    Article  Google Scholar 

  45. Peitzmeier SM, Malik M, Kattari SK, Marrow E, Stephenson R, Agénor M, et al. Intimate partner violence in transgender populations: systematic review and meta-analysis of prevalence and correlates. Am J Public Health. 2020;110(9):e1–14.

    Article  Google Scholar 

  46. Gazmararian JA, Lazorick S, Spitz AM, Ballard TJ, Saltzman LE, Marks JS. Prevalence of violence against pregnant women. JAMA. 1996;275(24):1915–20.

    Article  CAS  Google Scholar 

  47. Alhusen JL, Ray E, Sharps P, Bullock L. Intimate partner violence during pregnancy: maternal and neonatal outcomes. J Women’s Health. 2015;24(1):100–6.

    Article  Google Scholar 

  48. Donovan BM, Spracklen CN, Schweizer ML, Ryckman KK, Saftlas AF. Intimate partner violence during pregnancy and the risk for adverse infant outcomes: a systematic review and meta-analysis. BJOG Int J Obstet Gynaecol. 2016;123(8):1289–99.

    Article  CAS  Google Scholar 

  49. Intimate Partner Violence [cited 2020 Dec 23]. Available from https://www.acog.org/en/Clinical/Clinical Guidance/Committee Opinion/Articles/2012/02/Intimate Partner Violence

  50. Dicola D, Spaar E. Intimate partner violence. Am Fam Physician. 2016;94(8):646–51.

    Google Scholar 

  51. Leifheit KM, Schwartz GL, Pollack CE, Edin KJ, Black MM, Jennings JM, et al. Severe housing insecurity during pregnancy: association with adverse birth and infant outcomes. Int J Environ Res Public Health. 2020;17(22):8659.

    Article  Google Scholar 

  52. Russomanno J, Jabson Tree JM. Food insecurity and food pantry use among transgender and gender non-conforming people in the Southeast United States. BMC Public Health. 2020;20(1):590.

    Article  Google Scholar 

  53. Borders AEBM, Grobman WAM, Amsden LBM, Holl JLM. Chronic stress and low birth weight neonates in a low-income population of women. Obstet Gynecol. 2007;109:331–8.

    Article  Google Scholar 

  54. Laraia BA, Siega-Riz AM, Gundersen C. Household food insecurity is associated with self-reported pregravid weight status, gestational weight gain, and pregnancy complications. J Am Diet Assoc. 2010;110(5):692–701.

    Article  Google Scholar 

  55. US Preventive Services Task Force, Bibbins-Domingo K, Grossman DC, Curry SJ, Davidson KW, Epling JW, et al. Folic acid supplementation for the prevention of neural tube defects: US Preventive Services Task Force recommendation statement. JAMA. 2017;317(2):183.

    Article  Google Scholar 

  56. Wilson RD, Wilson RD, Audibert F, Brock J-A, Carroll J, Cartier L, et al. Pre-conception folic acid and multivitamin supplementation for the primary and secondary prevention of neural tube defects and other folic acid-sensitive congenital anomalies. J Obstet Gynaecol Can. 2015;37(6):534–49.

    Article  Google Scholar 

  57. Weight gain during pregnancy. Committee Opinion No. 548. American College of Obstetricians and Gynecologists. Obstet Gynecol. 2013;121:210–2.

    Google Scholar 

  58. Woody CA, Ferrari AJ, Siskind DJ, Whiteford HA, Harris MG. A systematic review and meta-regression of the prevalence and incidence of perinatal depression. J Affect Disord. 2017;219:86–92.

    Article  CAS  Google Scholar 

  59. Wisner KL, Sit DKY, McShea MC, Rizzo DM, Zoretich RA, Hughes CL, et al. Onset timing, thoughts of self-harm, and diagnoses in postpartum women with screen-positive depression findings. JAMA Psychiatry. 2013;70(5):490.

    Article  Google Scholar 

  60. MacDonald T, Noel-Weiss J, West D, Walks M, Biener M, Kibbe A, et al. Transmasculine individuals’ experiences with lactation, chestfeeding, and gender identity: a qualitative study. BMC Pregnancy Childbirth. 2016;16(16):106.

    Article  Google Scholar 

  61. Glynn TR, Gamarel KE, Kahler CW, Iwamoto M, Operario D, Nemoto T. The role of gender affirmation in psychological well-being among transgender women. Psychol Sex Orientat Gend Divers. 2016;3(3):336–44.

    Article  Google Scholar 

  62. Besse M, Lampe NM, Mann ES. Experiences with achieving pregnancy and giving birth among transgender men: a narrative literature review. Yale J Biol Med. 2020;93(4):517–28.

    Google Scholar 

  63. Hoffkling A, Obedin-Maliver J, Sevelius J. From erasure to opportunity: a qualitative study of the experiences of transgender men around pregnancy and recommendations for providers. BMC Pregnancy Childbirth. 2017;17(Suppl 2):332.

    Article  Google Scholar 

  64. Kritsotakis G, Vassilaki M, Melaki V, Georgiou V, Philalithis AE, Bitsios P, et al. Social capital in pregnancy and postpartum depressive symptoms: a prospective mother–child cohort study (the Rhea study). Int J Nurs Stud. 2013;50(1):63–72.

    Article  Google Scholar 

  65. Amjad S, MacDonald I, Chambers T, Osornio-Vargas A, Chandra S, Voaklander D, et al. Social determinants of health and adverse maternal and birth outcomes in adolescent pregnancies: a systematic review and meta-analysis. Paediatr Perinat Epidemiol. 2019;33(1):88–99.

    Article  Google Scholar 

  66. Rodriquez EJ, Kim EN, Sumner AE, Nápoles AM, Pérez-Stable EJ. Allostatic load: importance, markers, and score determination in minority and disparity populations. J Urban Health. 2019;96(Suppl 1):3–11.

    Article  Google Scholar 

  67. Gestational hypertension and preeclampsia [cited 2021 Jan 19]. Available from https://www.acog.org/en/Clinical/Clinical Guidance/Practice Bulletin/Articles/2020/06/Gestational Hypertension and Preeclampsia

  68. Management of preterm labor [cited 2021 Jan 19]. Available from https://www.acog.org/en/Clinical/Clinical Guidance/Practice Bulletin/Articles/2016/10/Management of Preterm Labor

  69. Prevalence of anaemia in pregnant women (%) [cited 2021 Jan 19]. Available from http://www.who.int/data/gho/data/indicators/indicator-details/GHO/prevalence-of-anaemia-in-pregnant-women-(-)

  70. Oyelese Y, Ananth CV. Placental abruption. Obstet Gynecol. 2006 Oct;108(4):1005–16.

    Article  Google Scholar 

  71. Martin JA, et al. Births: final data for 2018. Natl Vital Stat Rep. 2019;68(13):47.

    Google Scholar 

  72. Cesarean delivery on maternal request [cited 2020 Dec 28]. Available from https://www.acog.org/en/Clinical/Clinical Guidance/Committee Opinion/Articles/2019/01/Cesarean Delivery on Maternal Request

  73. Czech I, Fuchs P, Fuchs A, Lorek M, Tobolska-Lorek D, Drosdzol-Cop A, et al. Pharmacological and non-pharmacological methods of labour pain relief—establishment of effectiveness and comparison. Int J Environ Res Public Health 2018 [cited 2021 Jan 11];15(12). Available from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6313325/

  74. Dutton L, Koenig K, Fennie K. Gynecologic care of the female-to-male transgender man. J Midwifery Womens Health. 2008;53(4):331–7.

    Article  Google Scholar 

  75. Reisman T, Goldstein Z. Case report: induced lactation in a transgender woman. Transgender Health. 2018;3(1):24–6.

    Article  Google Scholar 

  76. Spironolactone. In: Drugs and lactation database (LactMed). Bethesda, MD: National Library of Medicine (US); 2006 [cited 2020 Dec 13]. Available from http://www.ncbi.nlm.nih.gov/books/NBK501101/

  77. Testosterone. In: Drugs and lactation database (LactMed). Bethesda, MD: National Library of Medicine (US); 2006 [cited 2020 Dec 13]. Available from http://www.ncbi.nlm.nih.gov/books/NBK501721/

  78. Hoover KL, Barbalinardo LH, Platia MP. Delayed lactogenesis II secondary to gestational ovarian theca lutein cysts in two normal singleton pregnancies. J Hum Lact. 2002;18(3):264–8.

    Article  Google Scholar 

  79. Glaser RL, Newman M, Parsons M, Zava D, Glaser-Garbrick D. Safety of maternal testosterone therapy during breast feeding. Int J Pharm Compd. 2009;13(4):314–7.

    Google Scholar 

  80. Aswathi A, Rajendiren S, Nimesh A, Philip RR, Kattimani S, Jayalakshmi D, et al. High serum testosterone levels during postpartum period are associated with postpartum depression. Asian J Psychiatry. 2015;17:85–8.

    Article  CAS  Google Scholar 

  81. Boudreau D, Mukerjee R. Contraception care for transmasculine individuals on testosterone therapy. J Midwifery Womens Health. 2019;64(4):395–402.

    Article  Google Scholar 

  82. Dehlendorf C, Grumbach K, Schmittdiel JA, Steinauer J. Shared decision making in contraceptive counseling. Contraception. 2017;95(5):452–5.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Daphna Stroumsa .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Indig, G., Ramos, S., Stroumsa, D. (2023). Obstetric, Antenatal, and Postpartum Care for Transgender and Nonbinary People. In: Moravek, M.B., de Haan, G. (eds) Reproduction in Transgender and Nonbinary Individuals. Springer, Cham. https://doi.org/10.1007/978-3-031-14933-7_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-14933-7_6

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-14932-0

  • Online ISBN: 978-3-031-14933-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics